Skip to main content
. 2009 Jul 8;2009(3):CD006529. doi: 10.1002/14651858.CD006529.pub2

Comparison 12. Patients with at least some adverse events (Tolerability).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Milnacipran vs TCAs 6 795 Odds Ratio (M‐H, Random, 95% CI) 0.35 [0.24, 0.53]
1.1 Milnacipran vs Imipramine 4 562 Odds Ratio (M‐H, Random, 95% CI) 0.43 [0.28, 0.66]
1.2 Milnacipran vs Amitriptyline 2 233 Odds Ratio (M‐H, Random, 95% CI) 0.23 [0.13, 0.40]
2 Milnacipran vs SSRIs 5 912 Odds Ratio (M‐H, Random, 95% CI) 0.86 [0.55, 1.34]
2.1 Milnacipran vs Fluvoxamine 2 240 Odds Ratio (M‐H, Random, 95% CI) 0.51 [0.28, 0.94]
2.2 Milnacipran vs Fluoxetine 2 370 Odds Ratio (M‐H, Random, 95% CI) 0.90 [0.49, 1.67]
2.3 Milnacipran vs Paroxetine 1 302 Odds Ratio (M‐H, Random, 95% CI) 1.45 [0.87, 2.43]
3 Milnacipran vs Heterocyclics 1 179 Odds Ratio (M‐H, Random, 95% CI) 0.62 [0.34, 1.15]
3.1 Milnacipran vs Mianserin 1 179 Odds Ratio (M‐H, Random, 95% CI) 0.62 [0.34, 1.15]